Abbott India has informed that the Board of Directors of the Company at its meeting held on June 03, 2013, has decided to defer the proposal received by the Company for the sale and transfer of, or other appropriate restructuring of, the proprietary pharmaceuticals division of the Company.
The above information is a part of company’s filings submitted to BSE.